Updates are available Correction dated 2025-06-04
Click to view Correction: https://doi.org/10.1007/s13300-025-01758-z
-
Authors
Pradeepa, Rajendra
PramodKumar, Thyparambil Aravindakshan
Anjana, Ranjit Mohan
Jebarani, Saravanan
Naziyagulnaaz, Abdul Subhan
Ganesan, Sadasivam
Premananth, Natarajan
Oomman, Abraham
Kumar, Soumitra
Jayagopal, Pathiyil Balagopalan
Wander, Gurpreet Singh
Mullasari, Ajit
Narula, Jagat
Jain, Sanjay
Swami, Onkar C.
Mohan, Viswanathan https://orcid.org/0000-0001-5038-6210
-
Funding
Funding for this research was provided by:
Alembic Pharmaceuticals Limited (#12026725)
- License Information
-
More Information
Article History
Received: 20 March 2025
Accepted: 17 April 2025
First Online: 8 May 2025
Change Date: 19 August 2025
Change Type: Update
Change Details: The original article was revised due to update in author name.
Change Date: 4 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13300-025-01758-z
Declarations
:
: Rajendra Pradeepa, Thyparambil Aravindakshan PramodKumar, Ranjit Mohan Anjana, Saravanan Jebarani, Abdul Subhan Naziyagulnaaz, Sadasivam Ganesan, Natarajan Premananth, Abraham Oomman, Soumitra Kumar, P.B.Jayagopal, Gurpreet Singh Wander, Ajit Mullasari, Jagat Narula and Viswanathan Mohan do not have any conflicts of interest. Sanjay Jain and Onkar Swami are employees of Alembic Pharmaceuticals Limited.
: The study was approved by the institutional ethics committee of Madras Diabetes Research Foundation (approval no. MDRF/NCT/01/02/2024). Written informed consent was obtained from all participants to the use of their anonymized data for research purposes.
